Fresenius SE & Co. KGaA
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a FSNUY research report →
About the company
Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. It operates through the following segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios and Fresenius Vamed.
- CEO
- Michael Sen
- IPO
- 2012
- Employees
- 178,394
- HQ
- Bad Homburg, DE
Price Chart
- Market Cap
- $109.04B
- P/E
- 15.95
- P/S
- 1.04
- P/B
- 1.20
- EV/EBITDA
- 9.37
- Div Yield
- 2.47%
- Gross Margin
- 25.25%
- Op Margin
- 9.45%
- Net Margin
- 6.38%
- ROE
- 7.76%
- ROIC
- 4.54%
- Revenue
- $21.97B · 0.63%
- Net Income
- $1.21B · 157.77%
- EPS
- $0.14 · 157.14%
- Op Income
- $2.09B
- FCF YoY
- -24.49%
- 52W High
- $33.93
- 52W Low
- $10.33
- 50D MA
- $11.43
- 200D MA
- $13.54
- Beta
- 0.82
- Avg Volume
- 186.53K
Get TickerSpark's AI analysis on FSNUY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our FSNUY coverage
Recent articles, reports, and earnings notes.
No research on FSNUY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate FSNUY report →Similar companies
Peers in the same neighborhood.